Isolation and in vivo activities of antifungal compounds from Myxococcus sp. JW154 (myxobacteria)

Korean Journal of Applied Microbiology and Biotechnology

Volumn 30, Issue 2, 2002, Pages 162-166

  Ahn, Jong Woong ^a   Kim, Byung Sup ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

In vivo antifungal activity; KR025; Melithiazole F; Myxobacteria; Myxococcus sp.

Indexed keywords

ANTIFUNGAL AGENT; BITHIAZOLE DERIVATIVE; KR 025; MELITHIAZOLE F; UNCLASSIFIED DRUG;

ANTIBIOTIC BIOSYNTHESIS; ANTIFUNGAL ACTIVITY; ARTICLE; BARLEY; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; IN VIVO STUDY; KOREA; MYXOCOCCUS; NONHUMAN; PLANT DISEASE; SCANNING ELECTRON MICROSCOPY; SEDIMENT; TOMATO; WHEAT;

MYXOCOCCUS;

EID: 0036315247     PISSN: 02572389     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. KR025, a new cytotoxic compound from Myxococcus fulvus
2. Cancer drugs better than taxol?
3. Myxothiazol, an antibiotic from Myxococcusfulvus
4. Studies on the taxonomy of the Myxobacterales
5. Cystothiazoles A and B, new bithiazole-type antibiotics from Cystobacter fulvus
6. Myxobacteria as producers of secondary metabolites
7. The Myxobacteria
8. Myxobacteria: A source of new antibiotics
9. Melithiazoles, new β-methoxyacrylate inhibitors of the respiratory chain isolated from Myxobacteria
10. Epothilones: Promising natural products with taxol-like activity
11. Myxobacteria-bacteria forming fruiting body
12. Isolation and identification of myxobacteria